Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple SclerosisTomáš Kalinčík, John A. Snowden, Harold Atkins et al.|JAMA Neurology|2023Cited by 55
Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosisTomáš Kalinčík, John A. Snowden, Sifat Sharmin et al.|Journal of Neurology Neurosurgery & Psychiatry|2024Cited by 10